Zenotech Laboratories

Zenotech Laboratories Short-term Debt

Short-Term Debt of Zenotech Laboratories (532039.BO) as of Nov 22, 2026.

Short-term Debt

0.00INR

Last updated:

Short-Term Debt of Zenotech Laboratories is 2025 0.00 INR. Short-Term Debt of Zenotech Laboratories was 2024 0.00 INR. It decreases by % lower compared to the previous year.

The Zenotech Laboratories Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2017
512.00 M INR
Jan 1, 2018
0.00 INR
Jan 1, 2019
202.40 M INR
Jan 1, 2020
186.56 M INR
Jan 1, 2021
0.00 INR
Jan 1, 2022
0.00 INR
Jan 1, 2024
0.00 INR
Jan 1, 2025
0.00 INR
The Zenotech Laboratories Short-term Debt history
YEARShort-term DebtYoY
0.00INR—
0.00INR—
0.00INR—
0.00INR-100.00%
186.56 MINR-7.83%
202.40 MINR—
0.00INR-100.00%
512.00 MINR0.00%
512.00 MINR-5.74%
543.16 MINR+15.77%
469.19 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

On Eulerpool you can find the complete historical development of Short-Term Debt Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories